Alec Machiels
CIK 1496687 · last filed 2026-05-14
Alec Machiels is a corporate insider who has filed 57 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for APLS, was dated May 14, 2026. Across all open-market trades the lifetime net is −$4.1M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
57
-$4.10M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Director | 0 | $41.03 | $0 | -$4.10M | 55 | 2026-05-14 |
| CREATIVE REALITIES, INC. (CREXW) Delisted | Director | 6,352 | $0.00 | $27 | $0 | 2 | 2019-10-03 |
Recent Filings
57 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | −817,250 | $0 | EDGAR |
| 2026-01-05 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +7,961 | $0 | EDGAR |
| 2025-01-03 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +6,267 | $0 | EDGAR |
| 2024-01-02 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +3,341 | $0 | EDGAR |
| 2023-11-20 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | — | -$56.3K | EDGAR |
| 2023-10-18 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | — | -$57.3K | EDGAR |
| 2023-09-19 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | — | -$52.9K | EDGAR |
| 2023-09-18 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | — | -$53.3K | EDGAR |
| 2023-07-24 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +49,779 | $132.9K | EDGAR |
| 2023-07-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +50,000 | $133.5K | EDGAR |